In addition, the expression of EGFR was reported in conjunction with insulinlike growth factor 1 receptor (IGF-1R) to predict poor survival in pancreatic ductal adenocarcinoma [21]. This evidence concerns the gene EGFR and pancreatic ductal adenocarcinoma.